A research team at the University of Birmingham has discovered a protein in adult skin cells that it hopes may lead to gene therapies for psoriasis and other skin diseases.
Among systemic therapies for psoriasis, the rate of treatment discontinuation was lowest with certain therapies, according to a study in the Journal of Managed Care & Specialty Pharmacy.
Health plans will likely save money after the launch of a combination psoriasis lotion, according to recent study findings.
Patients with late-onset psoriasis were more likely to respond to certain treatments than patients with early-onset psoriasis, according to a study published in the American Journal of Clinical Dermatology.
For patients with moderate to severe plaque psoriasis with an inadequate response to methotrexate and phototherapy, researchers have investigated whether or not IL-17 inhibitors are an effective treatment strategy.